Antiseizure medications during pregnancy linked to neurodevelopmental risks in children

Children born to mothers who take antiseizure medications to manage seizures and psychiatric conditions during pregnancy may face increased risks of neurodevelopmental conditions, according to new data from researchers at Drexel’s Dornsife School of Public Health.

NM-6603 by Nucmito for Melanoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 23, 2024

Study finds low-dose calcium as effective as the WHO’s recommended high-dose in preventing preeclampsia and preterm births

Researchers assessed the noninferiority of a 500-mg daily dose of calcium supplementation compared to a 1500-mg dose in preventing preeclampsia and preterm birth in pregnant

January 16, 2024

PepGen earns FDA fast track designation for myotonic dystrophy type 1 candidate – Pharmaceutical Technology

Share this article PepGen develops therapies for severe neuromuscular diseases. Image credit: Shutterstock/MacroEcon. The US Food and Drug Administration (FDA) has granted fast track designation

February 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.